Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective treatments. The gap between the scale of the problem and the funding response ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

New weight-loss drugs promise transformative benefits, but soaring demand and massive cost projections leave Ireland facing ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to ...

Novo Nordisk says it is taking a flexible portfolio approach and plans to price the injectable semaglutide close to Wegovy’s ...

Ozempic was launched in India on Friday (December 12). The blockbuster drug by Novo Nordisk will be marketed for adults with type-2 diabetes, unlike in the US and Europe where it is also sold as ...

Jelly Roll, Ashley Tisdale, Chrissy Teigen, Meghan Trainor and more celebs who've talked about semaglutide drugs including ...

A Division Bench of Delhi High Court on Friday declined to stay a Single Judge’s order that had allowed Dr Reddy’s ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...